Newsletters

Engineered Human iPSC-Derived Dendritic Cells Dressed with Tumor MHC Complexes As a Cancer Vaccine

[Cell Stem Cell] Investigators presented an approach that involves differentiating universal major histocompatibility complex (MHC)-deficient hiPSCs into CCR7+ migratory dendritic cells.

Modeling Sympathetic Neuro-Cardiac Interactions in a hiPSC-Based Microphysiological System

[Lab on a Chip] The authors presented a novel microphysiological system using a compartmentalized microfluidic device to integrate co-cultured hiPSC-derived cardiomyocytes and sympathetic neurons.

Induction of Human Pruriceptors from Pluripotent Stem Cells via Transcription Factors

[Stem Cell Reports] The therapeutic potential of autologous-derived dendritic cells is challenged by the number and quality produced and the diversity of antigens presented. Researchers addressed this limitation by developing a protocol to generate induced pruriceptors from hiPSCs.

Single Cell CRISPR Screen Identifies Antagonism Between Nsd1-H3K36me2 and Ezh2-H3K27me3 Orchestrates Pluripotency Transition

[Stem Cell Reports] Scientists employed CRISPR/Cas9-based functional screening coupled with single-cell RNA-seq to investigate the epigenetic regulation governing the pluripotency network in mESCs.

Derivation of Human Post-Mitotic Cardiomyocytes from Tetraploid iPSCs

[Communications Biology] Researchers developed a strategy to establish human tetraploid iPSC (4N-iPSC) through cell fusion and found that iPSC-derived cardiomyocytes (iPS-CMs) derived from 4N-iPSCs were phenotypically similar to post-mitotic cardiomyocytes and were distinct from conventional iPS-CMs.

CRISPR/Cas9-Based Repair of a Heterozygous HNF1A Mutation in Patient-Derived hiPSCs

[Human Genetics] Investigators described an optimized CRISPR-based strategy for correcting a heterozygous HNF1A frameshift mutation in HNF1A-MODY patient-derived hiPSCs.

Stem Cell Therapies for Treatment of Diabetes Mellitus

[Chinese Medical Journal] Scientists summarize the recent advancements and molecular mechanisms of stem cells (SCs) in the treatment of diabetes mellitus (DM), underscoring the feasibility, benefits, and current limitations of SC therapy for DM, and offering a lucid perspective on their therapeutic possibilities.

Greenstone Biosciences Awarded Breakthrough T1D Grant to Advance Type 1 Diabetes-Derived Islet Cell Platform for Research and Development

[Breakthrough T1D] Greenstone Biosciences has been awarded a Breakthrough T1D Industry Discovery and Development Partnership (IDDP) grant to develop a T1D-derived islet cell platform aimed at understanding and protecting insulin-producing β cells in people with type 1 diabetes (T1D).

Maternal Influences on Infant Gut Microbiome and Health

[Nature] Researchers metagenomically sequenced 4,526 longitudinal fecal samples from 714 mother–infant pairs. They observed that the maternal gut microbiome undergoes only subtle changes during pregnancy and postpartum, influenced by diet, infections, and pre-pregnancy smoking.

In Vivo Genome-Wide CRISPR Screens of Human T Cells in Solid Tumours

[Nature] Scientists developed an in vivo model that efficiently recovers human T cells from solid tumours, permitting genome-wide CRISPR screens with few mice. Tumor-infiltrating T cells from this model exhibit hallmarks of dysfunction compared with splenic T cells, creating an ideal screening context.

PRMT5-Mediated Intron Retention Triggers Innate and Adaptive Immunity against Cancer

[EMBO Molecular Medicine] Scientists defined a new role for PRMT5 in regulating and coordinating the interplay between the innate and adaptive immune response.

A Single-Cell Transcriptomic Atlas Reveals the Immune Panorama of Neonatal Sepsis

[Cell Reports] The authors performed single-cell RNA sequencing on 26 blood samples from 18 neonates, spanning acute sepsis, convalescence, and healthy controls. They identified 57 cell subtypes, revealing acute lymphoid depletion and myeloid expansion.
spot_img